Join senior pharmaceutical, biotechnology, AI, and translational medicine leaders for a curated executive breakfast exploring how artificial intelligence, biomarkers, and computational biology are reshaping the future of drug discovery.
The Pharmalyzer Discovery Breakfast London 2026 brings together senior executives, scientific innovators, AI pioneers, and translational medicine leaders for a focused morning of strategic discussion and high-value networking.
Unlike large-scale conferences, this event prioritises executive-level dialogue, curated introductions, and relationship-driven engagement, creating space for meaningful conversations around the practical application of AI in drug discovery.
We are in the process of confirming senior industry leaders and scientific experts to lead discussions across our fireside and panel sessions. Speaker announcements coming soon.
Explore how AI and translational science are influencing modern drug discovery pipelines.
Connect directly with senior decision-makers from pharma, biotech, AI, and innovation companies.
Engage in a focused, invitation-only setting designed for meaningful, high-trust conversations.
Discover new collaborations across therapeutic innovation, AI platforms, biomarkers, and R&D technology.
Pharmalyzer Global offers strategic partnership opportunities for organisations seeking meaningful engagement with senior pharmaceutical and biotechnology leaders.
Reach out to our team to discuss how we can create a tailored partnership package for your organisation.
Join senior leaders shaping the future of AI-powered drug discovery and translational innovation.